LABCORP HOLDINGS INC. — Director's Dealing 2024

Feb 13, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2024-02-11

Reporting Person: Schroeder Mark S (EVP, Pres Diagnostics & COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-11	Common Stock	M	472	—	Acquired	8091.1426	Direct
2024-02-12	Common Stock	F	126	$227.45	Disposed	7965.1426	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-11	Restricted Stock Unit	$	M	472	Disposed		Common Stock (472)	Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Stock withholding to satisfy tax withholding obligations.

F3: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2023.

F4: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.